235 related articles for article (PubMed ID: 27958228)
1. Apoptotic Mechanism of Human Leukemia K562/A02 Cells Induced by Magnetic Ferroferric Oxide Nanoparticles Loaded with Wogonin.
Peng MX; Wang XY; Wang F; Wang L; Xu PP; Chen B
Chin Med J (Engl); 2016 Dec; 129(24):2958-2966. PubMed ID: 27958228
[TBL] [Abstract][Full Text] [Related]
2. Effect of magnetic nanoparticles of Fe3O4 and wogonin on the reversal of multidrug resistance in K562/A02 cell line.
Cheng J; Cheng L; Chen B; Xia G; Gao C; Song H; Bao W; Guo Q; Zhang H; Wang X
Int J Nanomedicine; 2012; 7():2843-52. PubMed ID: 22745547
[TBL] [Abstract][Full Text] [Related]
3. Effect of magnetic nanoparticles on apoptosis and cell cycle induced by wogonin in Raji cells.
Wang L; Zhang H; Chen B; Xia G; Wang S; Cheng J; Shao Z; Gao C; Bao W; Tian L; Ren Y; Xu P; Cai X; Liu R; Wang X
Int J Nanomedicine; 2012; 7():789-98. PubMed ID: 22359456
[TBL] [Abstract][Full Text] [Related]
4. Apoptotic mechanism of human leukemia K562/A02 cells induced by magnetic iron oxide nanoparticles co-loaded with daunorubicin and 5-bromotetrandrin.
Wang J; Chen B; Cheng J; Cai X; Xia G; Liu R; Wang X
Int J Nanomedicine; 2011; 6():1027-34. PubMed ID: 21720514
[TBL] [Abstract][Full Text] [Related]
5. Reversal in multidrug resistance by magnetic nanoparticle of Fe3O4 loaded with adriamycin and tetrandrine in K562/A02 leukemic cells.
Chen B; Sun Q; Wang X; Gao F; Dai Y; Yin Y; Ding J; Gao C; Cheng J; Li J; Sun X; Chen N; Xu W; Shen H; Liu D
Int J Nanomedicine; 2008; 3(2):277-86. PubMed ID: 18686787
[TBL] [Abstract][Full Text] [Related]
6. Wogonin reverses multi-drug resistance of human myelogenous leukemia K562/A02 cells via downregulation of MRP1 expression by inhibiting Nrf2/ARE signaling pathway.
Xu X; Zhang Y; Li W; Miao H; Zhang H; Zhou Y; Li Z; You Q; Zhao L; Guo Q
Biochem Pharmacol; 2014 Nov; 92(2):220-34. PubMed ID: 25264278
[TBL] [Abstract][Full Text] [Related]
7. Effect of magnetic nanoparticles of Fe3O4 and 5-bromotetrandrine on reversal of multidrug resistance in K562/A02 leukemic cells.
Cheng J; Wu W; Chen BA; Gao F; Xu W; Gao C; Ding J; Sun Y; Song H; Bao W; Sun X; Xu C; Chen W; Chen N; Liu L; Xia G; Li X; Wang X
Int J Nanomedicine; 2009; 4():209-16. PubMed ID: 19918367
[TBL] [Abstract][Full Text] [Related]
8. Synergistic effect of the combination of nanoparticulate Fe3O4 and Au with daunomycin on K562/A02 cells.
Chen BA; Dai YY; Wang XM; Zhang RY; Xu WL; Shen HL; Gao F; Sun Q; Deng XJ; Ding JH; Gao C; Sun YY; Cheng J; Wang J; Zhao G; Chen NN
Int J Nanomedicine; 2008; 3(3):343-50. PubMed ID: 18990943
[TBL] [Abstract][Full Text] [Related]
9. A Novel Prostate-Specific Membrane-Antigen (PSMA) Targeted Micelle-Encapsulating Wogonin Inhibits Prostate Cancer Cell Proliferation via Inducing Intrinsic Apoptotic Pathway.
Zhang H; Liu X; Wu F; Qin F; Feng P; Xu T; Li X; Yang L
Int J Mol Sci; 2016 May; 17(5):. PubMed ID: 27196894
[TBL] [Abstract][Full Text] [Related]
10. Differential apoptotic effect of wogonin and nor-wogonin via stimulation of ROS production in human leukemia cells.
Chow JM; Huang GC; Shen SC; Wu CY; Lin CW; Chen YC
J Cell Biochem; 2008 Apr; 103(5):1394-404. PubMed ID: 17955493
[TBL] [Abstract][Full Text] [Related]
11. [Effect of desferrioxamine on K562/A02 cell line and its mechanism].
Cheng J; Wang T; Chen BA; Ding JH; Gao C; Xia GH; Bao W; Song HH; Xu WL; Shen HL
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2011 Apr; 19(2):337-41. PubMed ID: 21518484
[TBL] [Abstract][Full Text] [Related]
12. Triptolide modulates the sensitivity of K562/A02 cells to adriamycin by regulating miR-21 expression.
Li H; Hui L; Xu W; Shen H; Chen Q; Long L; Zhu X
Pharm Biol; 2012 Oct; 50(10):1233-40. PubMed ID: 22957792
[TBL] [Abstract][Full Text] [Related]
13. [Effect of CD44 gene silence on multi-drug resistance reversal and biologic activity in K562/A02 cells].
Liu YP; Liu CF; Ma DX; Lu F; Zhang JJ; Kong HL
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2010 Apr; 18(2):335-9. PubMed ID: 20416163
[TBL] [Abstract][Full Text] [Related]
14. [Regulatory effect of ginsenoside Rh2 on HDAC1/2 activity and cyclin in human erythroleukemia K562 cells].
Xia J; Chen D; Zuo G; Wei Q; You Z; Li D; Liu Z; Li J
Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2014 Oct; 30(10):1062-6. PubMed ID: 25270209
[TBL] [Abstract][Full Text] [Related]
15. [Effect of YB-1 gene knockdown on human leukemia cell line K562/A02].
Xu WL; Zhou LL; Chen QY; Chen C; Fang LL; Fang XJ; Shen HL
Zhonghua Yi Xue Yi Chuan Xue Za Zhi; 2009 Aug; 26(4):400-5. PubMed ID: 20017303
[TBL] [Abstract][Full Text] [Related]
16. [Effect of PDMP, a glucosylceramide synthase inhibitor, on reversion of daunorubicin resistance in human leukemia cell line K562/A02].
Yin L; Chen BA; Cheng J; Ding JH; Gao C; Sun YY; Wang J; Zhao G; Gao F; Song HH; Bao W; Wu WW; Wang F; Liang YQ; Xia GH; Wang XM
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2010 Feb; 18(1):79-84. PubMed ID: 20137123
[TBL] [Abstract][Full Text] [Related]
17. [Inhibitory effect of wogonin on the proliferation and invasion of glioblastoma U87 cells and related mechanism].
Zeng Z; Liu H
Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2015 Mar; 31(3):302-6. PubMed ID: 25744831
[TBL] [Abstract][Full Text] [Related]
18. [Inhibitory Effect of Serum Containing Fuzheng Jiedu Decoction on the Leukemia K562/A02 Multi-drug Resistance Cells and Its Mechanism].
Cao YX; Luo ZY; Li JJ; Wen F; Huang LF
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2016 Aug; 24(4):1024-8. PubMed ID: 27531768
[TBL] [Abstract][Full Text] [Related]
19. miR-181a sensitizes a multidrug-resistant leukemia cell line K562/A02 to daunorubicin by targeting BCL-2.
Li H; Hui L; Xu W
Acta Biochim Biophys Sin (Shanghai); 2012 Mar; 44(3):269-77. PubMed ID: 22285729
[TBL] [Abstract][Full Text] [Related]
20. [Influence of YB-1 protein on the biological behaviour in K562/A02 cells].
Shen HL; Zhou LL; Chen QY; Chen C; Fang LL; Fang XJ; Xu WL
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2011 Apr; 19(2):342-7. PubMed ID: 21518485
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
